Trade Immuneering Corp - IMRX CFD

Trading Conditions

• Type: CFD
• Spread: 0.040
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 4.845
• Open: 4.715
• 1-Year Change: -5.04%
• Day's Range: 4.715 - 4.975

What is Immuneering Corp (IMRX)?

Immuneering Corp is a biotechnology firm engaged in the discovery and development of therapeutics targeting neurodegenerative diseases and cancer. The company utilizes computational biology and machine learning to identify novel drug targets and accelerate the drug discovery process. Its platform integrates biological data with advanced analytics to develop small molecule therapies aimed at modifying disease progression. Immuneering Corp collaborates with research institutions and industry partners to advance its pipeline and contribute to the development of innovative treatments for complex diseases.

Immuneering Corp Stock Price Today: Live Overview

The price today is shaped by market activity as Oil-Dri Corp of America trades at $5.015. The intraday range covers prices between $4.705 and $5.005, with a daily change percentage of 0%.

FAQ: Immuneering Corp (IMRX)

What is the current price of IMRX stock?

Immuneering Corp's latest trading price is $5.015.

Does IMRX pay dividends?

Immuneering Corp does not distribute dividends.

Does IMRX have a formal corporate presence or regional headquarters in the UAE?

Immuneering Corp does not have a registered presence or subsidiary in the UAE and conducts business through partners.

What is IMRX best known for?

Immuneering Corp is most famous for its AI-driven drug discovery technologies.

What assets are typically shown together with IMRX?

Commonly shown alongside IMRX: Solid Power Inc, Serve Robotics Inc, Ingles Markets Inc